Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis最新文献_第9页

Neonatal alloimmune thrombocytopenia. 新生儿同种免疫性血小板减少症。

Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis Pub Date : 2002-02-01 DOI: 10.1046/J.1526-0968.2002.00397.X

S. Rothenberger

引用次数: 15

Continuous arterial infusion of prostaglandin E(1) via the superior mesenteric artery in the treatment of postoperative liver failure. 经肠系膜上动脉持续动脉输注前列腺素E(1)治疗术后肝衰竭。

Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis Pub Date : 2002-02-01 DOI: 10.1046/J.1526-0968.2002.00332.X

Y. Asanuma, Tsutomu Sato, Takeshi Kato, H. Nanjo, T. Kurokawa, O. Yasui, K. Koyama

{"title":"Continuous arterial infusion of prostaglandin E(1) via the superior mesenteric artery in the treatment of postoperative liver failure.","authors":"Y. Asanuma, Tsutomu Sato, Takeshi Kato, H. Nanjo, T. Kurokawa, O. Yasui, K. Koyama","doi":"10.1046/J.1526-0968.2002.00332.X","DOIUrl":"https://doi.org/10.1046/J.1526-0968.2002.00332.X","url":null,"abstract":"Impaired hepatic blood flow is one of the causative factors in postoperative liver failure. To restore the hepatic blood flow in case of hepatic artery interruption (HAI), the effect of continuous arterial infusion of prostaglandin E(1) (PGE(1)), which has a strong vasodilatory effect on vascular smooth muscles, was assessed experimentally and clinically. Twelve pigs underwent ligation and division of the hepatic artery and were divided into 2 groups. In the control group, saline was infused in the superior mesenteric artery (SMA), and in the PGE(1) group, 0.02 microg/kg/min of PGE(1) was infused continuously in the SMA. Hepatic oxygen delivery (HDO(2)) in the control group was 87.8 +/- 8.9 ml/min before HAI and decreased to 43.1 +/- 2.6 ml/min at 60 min after HAI, showing 50.9% decrease by HAI. On the contrary, HDO(2) in the PGE(1) group was 86.7 +/- 9.1 ml/min before HAI and was 76.6 +/- 12.2 ml/min at 60 min after HAI, showing only 11.6% decrease by HAI. Clinically, a 65-year-old female suffering from cholangiocellular carcinoma underwent extended left hepatic lobectomy. At operation, the branch of the hepatic artery to the anterior segment of the liver was ligated, and the right branch of the portal vein became stenotic unavoidably. Postoperatively, severe liver dysfunction developed so that continuous PGE1 infusion in the SMA was initiated at a rate of 0.01 microg/kg/min on the eighth postoperative day and continued for 9 days. Plasma exchange was performed twice concomitantly. Portal venous flow increased from 612 ml/min to 1,192 ml/min, and bile flow from external biliary drainage tube doubled by the PGE(1) infusion. The liver function was ameliorated after PGE(1) infusion.","PeriodicalId":79755,"journal":{"name":"Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis","volume":"8 1","pages":"89-92"},"PeriodicalIF":0.0,"publicationDate":"2002-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73475623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4

Volunteer donor apheresis. 自愿捐献血液分离。

Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis Pub Date : 2002-02-01 DOI: 10.1046/J.1526-0968.2002.00395.X

D. Waxman

引用次数: 13

Myasthenia gravis and Lambert-Eaton syndrome. 重症肌无力和兰伯特-伊顿综合征。

Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis Pub Date : 2002-02-01 DOI: 10.1046/J.1526-0968.2002.00403.X

R. Pascuzzi

引用次数: 23

Myocardial infarction/injury is relatively common at presentation of acute thrombotic thrombocytopenic purpura: the Indiana University experience. 心肌梗死/损伤是相对常见的急性血栓性血小板减少性紫癜的表现:印第安纳大学的经验。

Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis Pub Date : 2002-02-01 DOI: 10.1046/J.1526-0968.2002.00363.X

L. Mccarthy, C. Danielson, E. Skipworth, S. Peters, C. Miraglia, A. Antony

引用次数: 51

A case report: first case of filtration leukocytapheresis for a patient of aortitis syndrome associated with ulcerative colitis. 一例报告:一例滤过性白细胞摘除术治疗溃疡性结肠炎伴主动脉炎综合征。

Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis Pub Date : 2002-02-01 DOI: 10.1046/J.1526-0968.2002.00317.X

K. Fukunaga, K. Sawada, Y. Fukuda, Yoshika Matoba, K. Onishi, S. Fukui, M. Yamamura, M. Satomi, T. Shimoyama

{"title":"A case report: first case of filtration leukocytapheresis for a patient of aortitis syndrome associated with ulcerative colitis.","authors":"K. Fukunaga, K. Sawada, Y. Fukuda, Yoshika Matoba, K. Onishi, S. Fukui, M. Yamamura, M. Satomi, T. Shimoyama","doi":"10.1046/J.1526-0968.2002.00317.X","DOIUrl":"https://doi.org/10.1046/J.1526-0968.2002.00317.X","url":null,"abstract":"An 18-year-old woman was treated with leukocytapheresis (LCAP) for her combined ulcerative colitis (UC) and aortitis syndrome (AS). Because a close relationship between these two diseases has been suspected based on their etiological and/or pathological findings, we had hypothesized that LCAP, which has satisfactory effects on inflammatory bowel disease such as UC and Crohn's disease might be effective for both her UC and her AS. After informed consent, LCAP therapy was performed once a week for a total of 7 times. Endoscopic remission of the UC was observed. Even though there were no significant improvements in her subjective symptoms of AS such as side-neck pain and dizziness, objective evidence of improvement was obtained when the patient's condition was compared before and after LCAP by angiography, angio-magnetic resonance imaging, and the plethysmogram of her fingertips. These results suggest that LCAP may be valuable as a new adjunct therapy for AS.","PeriodicalId":79755,"journal":{"name":"Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis","volume":"29 1","pages":"93-8"},"PeriodicalIF":0.0,"publicationDate":"2002-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89400612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 12

First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management. 建立德国低密度脂蛋白分离注册的第一步:适应症和质量管理建议。

Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis Pub Date : 2002-01-01 DOI: 10.1016/s1567-5688(03)90743-4

V. Schettler, E. Wieland, V. Armstrong, T. Kleinoeder, R. Grunewald, G. Müller

引用次数: 8

Effects of operating conditions on selectivity of a plasma fractionator in double filtration plasmapheresis. 双过滤血浆分离法中操作条件对等离子分离器选择性的影响。

Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis Pub Date : 2001-12-01 DOI: 10.1046/J.1526-0968.2001.00391.X

M. Mineshima, R. Yokoi, K. Horibe, K. Eguchi, I. Kaneko, T. Agishi, T. Akiba

{"title":"Effects of operating conditions on selectivity of a plasma fractionator in double filtration plasmapheresis.","authors":"M. Mineshima, R. Yokoi, K. Horibe, K. Eguchi, I. Kaneko, T. Agishi, T. Akiba","doi":"10.1046/J.1526-0968.2001.00391.X","DOIUrl":"https://doi.org/10.1046/J.1526-0968.2001.00391.X","url":null,"abstract":"In a typical double filtration plasmapheresis treatment, plasma fractionation between albumin and some immunoglobulins associated with toxins is limited because none of the currently available plasma fractionators has a strict cutoff property for these proteins. Selectivity of immunoglobulins over albumin depends not only on the cutoff properties of the membrane but on the operating conditions such as the flow rate of the supplied plasma (Q(P)) and retained plasma to be discarded (Q(D)) in the plasma fractionator. We carried out an in vitro study using human plasma harvested by single plasma exchange treatments to assess the selectivity of a plasma fractionator, Evaflux 2A-F (Kawasumi Laboratories, Inc., Tokyo, Japan), under various operating conditions. The results of rate-constant filtration experiments showed that the concentrations in the feed tank and the sieving coefficient (SC) values of every protein were decreased slightly within 2 h after the start of the experiment because of membrane trapping, adsorption, and/or plugging. The time-averaged SC value of albumin increased with flow rate ratio (Q(P)/Q(D)) due to increasing filtration fraction (FF), but relative removal efficiency (mD/mP*) for albumin decreased with Q(P)/ Q(D) due to decreasing Q(D). For immunoglobulins, on the other hand, the SC values were almost unchanged, and the mD/mP* values increased with Q(P)/Q(D) due to an increase in FF. Both increasing Q(P) and decreasing Q(D) are effective means of improving selectivity between these proteins in the plasma fractionator. Membrane fouling is, however, obvious beyond a Q(P)/Q(D) value that is thought to be a critical point. Operation should be conducted below the critical Q(P)/Q(D) value, which depends on the patient's plasma components and the cutoff property of the membrane.","PeriodicalId":79755,"journal":{"name":"Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis","volume":"20 1","pages":"444-8"},"PeriodicalIF":0.0,"publicationDate":"2001-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75356299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 5

Antibody elimination by apheresis in living donor liver transplant recipients. 活体肝移植受者单采抗体消除。

Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis Pub Date : 2001-12-01 DOI: 10.1046/J.1526-0968.2001.00376.X

N. Kawagishi, N. Ohkohchi, K. Fujimori, T. Orii, N. Koyamada, H. Kikuchi, S. Sekiguchi, S. Tsukamoto, T. Sato, S. Satomi

{"title":"Antibody elimination by apheresis in living donor liver transplant recipients.","authors":"N. Kawagishi, N. Ohkohchi, K. Fujimori, T. Orii, N. Koyamada, H. Kikuchi, S. Sekiguchi, S. Tsukamoto, T. Sato, S. Satomi","doi":"10.1046/J.1526-0968.2001.00376.X","DOIUrl":"https://doi.org/10.1046/J.1526-0968.2001.00376.X","url":null,"abstract":"In the present study, we investigated retrospectively the indications and the efficacy of the elimination of preexisting antiallogeneic antibodies in liver transplant recipients. Three patients who were ABO blood type incompatible were subjected to plasmapheresis and double filtration plasmapheresis before the living donor liver transplantation (LDLTx), and the titers decreased to less than 8. After transplantation, plasmapheresis was also performed in 3 cases, and continuous hemodiafiltration in 1 case, and in 2 out of these 3 patients acute rejection was recognized. Two patients who were crossmatch positive were subjected to plasmapheresis before transplantation, and the T warm titers were reduced to less than Score 2. These 2 patients had no acute rejections after transplantation. We conclude that in liver transplant patients apheresis is effective to prevent acute rejection induced by preexisting anti-A and/or anti-B antibodies and anti-donor specific antibodies before transplantation, but it is not effective in a patient with accelerated humoral rejection occurring after transplantation.","PeriodicalId":79755,"journal":{"name":"Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis","volume":"24 1","pages":"449-54"},"PeriodicalIF":0.0,"publicationDate":"2001-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81711466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 8

Plasma exchange for the treatment of human T-cell lymphotropic virus type 1 associated myelopathy. 血浆置换治疗人类t细胞嗜淋巴病毒1型相关脊髓病

Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis Pub Date : 2001-12-01 DOI: 10.1046/J.1526-0968.2001.00398.X

N. Narukawa, K. Shiizaki, Y. Kitabata, T. Abe, H. Kobata, T. Akizawa

{"title":"Plasma exchange for the treatment of human T-cell lymphotropic virus type 1 associated myelopathy.","authors":"N. Narukawa, K. Shiizaki, Y. Kitabata, T. Abe, H. Kobata, T. Akizawa","doi":"10.1046/J.1526-0968.2001.00398.X","DOIUrl":"https://doi.org/10.1046/J.1526-0968.2001.00398.X","url":null,"abstract":"A 55-year-old man was admitted to our hospital because of myelopathy. He had a history of chronic renal failure due to polycystic kidney disease at the age of 39, being treated by hemodialysis for 9 years with several blood transfusions for the treatment of renal anemia. After cadaver renal transplantation at the age of 48, he discontinued hemodialysis. At 50 years of age, he had pulmonary tuberculosis and tuberculous arthritis of the left elbow joint. He has experienced difficulty in walking since he was 48 years old, with mild dysuria. Gait disturbance gradually aggravated after that, and urinary retention was observed. When he was 55 years old, being human T-cell lymphotropic virus type-1 (HTLV-1)-positive in the serum and cerebrospinal fluid, he was diagnosed as having HTLV-1-associated myelopathy (HAM). As active steroid therapy was unapplicable because of the history of pulmonary tuberculosis and immunosuppression for transplanted kidney, a series of plasma exchanges (PE) was performed with fresh frozen plasma as a replacement fluid. After PE, dyskinesia of the left leg and dysuria subjectively and objectively improved. These results suggest that PE seems to be one of the therapeutic tools for the treatment of HAM.","PeriodicalId":79755,"journal":{"name":"Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis","volume":"50 1","pages":"491-3"},"PeriodicalIF":0.0,"publicationDate":"2001-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75800187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 12